PROLIFERATION OF MICROVASCULAR ENDOTHELIAL-CELLS IN THE PRIMATE CORPUS-LUTEUM DURING THE MENSTRUAL-CYCLE AND SIMULATED EARLY-PREGNANCY

Citation
Lk. Christenson et Rl. Stouffer, PROLIFERATION OF MICROVASCULAR ENDOTHELIAL-CELLS IN THE PRIMATE CORPUS-LUTEUM DURING THE MENSTRUAL-CYCLE AND SIMULATED EARLY-PREGNANCY, Endocrinology, 137(1), 1996, pp. 367-374
Citations number
40
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
00137227
Volume
137
Issue
1
Year of publication
1996
Pages
367 - 374
Database
ISI
SICI code
0013-7227(1996)137:1<367:POMEIT>2.0.ZU;2-1
Abstract
The objective of this study was to evaluate endothelial us. steroidoge nic cell proliferation throughout the lifespan of the primate corpus l uteum during the menstrual cycle and simulated early pregnancy (CG tre atment). Tissues were collected from rhesus monkeys (Macaca mulatta; n = 3/day) on days 3-4, 7, 10, 12, and 14 of the luteal phase and at me nses during spontaneous menstrual cycles and after 1, 3, 6, or 9 days of hCG treatment beginning on day 9 of the luteal phase. Corpora lutea were snap-frozen in mounting medium for immunocytochemical and histoc hemical evaluation. The labeling index (percentage of positive to tota l nuclei) for Ki-67 antigen, a cell proliferation marker, was determin ed in conjunction with cell-specific markers. Immunolocalization of pl atelet/endothelial cell adhesion molecule-1 and von Willebrand factor in addition to histochemical staining for the Ulex europaeus agglutini n-1 (i.e, lectin)-binding site were used to identify endothelial cells . Histochemical detection of 3 beta-hydroxysteroid dehydrogenase activ ity was used to identify steroidogenic cells. Progesterone secretion w as high on days 3-10 of the luteal phase and then declined progressive ly (P < 0.05) on days 12 and 14 and at menses; luteal weight followed a similar pattern, declining 2 days (i.e. day 14) after progesterone s ecretion. In contrast, after hCG treatment,luteal progesterone product ion increased (P < 0.05) 3-fold, and luteal weight was maintained. The cell proliferation index was greatest (44.5 +/- 1.9%) on days 3-4 of the luteal phase and remained high on days 7 and 10 (34.6 +/- 0.3% and 27.1 +/- 3.4%), but this was followed by a sharp decline on day 12 (9 .6 +/- 2.3%), which was sustained on day 14 and at menses. After 1 day of hCG treatment, cell proliferation was less than that observed on t he equivalent day of the luteal phase (day 10), but thereafter, it was similar on days 3, 6, and 9 of simulated early pregnancy to those in the late luteal phase of the menstrual cycle (i.e. day 12 to menses). Dual label immunocytochemistry indicated that more than 85% of cells s taining positively for the Ki-67 antigen costained for platelet/endoth elial cell adhesion molecule-1. No cells staining positively for both 3 beta-hydroxysteroid dehydrogenase activity and the Ki-67 antigen wer e noted. Thus, the level of cell proliferation within the primate corp us luteum varies during the luteal lifespan in the menstrual cycle, an d endothelial cells comprised the vast majority of proliferative cells , whereas steroidogenically active cells were not proliferating. Furth er, the elevated progesterone secretion and sustained luteal weight th at occurred during CG exposure simulating early pregnancy were not ass ociated with an increase or maintenance of cellular proliferation.